Endoscopy guided pancreatic fluid drainage and pancreatic duct stenting for pancreatic fluid collections
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: null- Pancreatic Pseudocyst
- Registration Number
- CTRI/2017/07/008956
- Lead Sponsor
- Endoscopy Research foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 41
Inclusion Criteria
Willing and able to comply with the study procedures and provide written informed consent to participate in the study
Symptomatic pancreatic fluid collection.
Exclusion Criteria
1)Pancreatic fluid collection > 1 cm away from stomach wall
2)Previous history of ERP and PD stenting.
3)Patients for whom endoscopic techniques are contraindicated
4)Participation in another investigational trial within 180 days
5)Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pancreatic pseudocyst formation and resolution in CTRI/2017/07/008956?
How does EUS-guided drainage with fully covered metal stents compare to standard percutaneous drainage for pseudocysts?
What biomarkers correlate with successful pancreatic duct stenting outcomes in pseudocyst management?
What are the potential adverse events associated with BIDS protocol in pancreatic fluid collections?
Are there combination therapies with EUS-guided stenting that improve pseudocyst resolution rates?